Top

Q301--New - NTX CareDx-Allomap

Active

36C25722Q0287Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Department of Veterans Affairs, through its Network Contracting Office 17, plans to award a sole source contract to Caredx Inc. for AlloMap Transplant Rejection Blood Testing services specifically for the Dallas VA Medical Center’s Pathology and Lab Medicine Department. This contract will be a firm fixed price agreement, covering one base period with four optional renewal periods. Caredx Inc. is uniquely qualified to provide this specialized genetic blood test, the AlloMap Molecular Expression test, which is FDA-approved and used to detect heart transplant rejection in post-transplant patients. The test is exclusively offered by this company, making it the sole provider capable of meeting the requirement. The solicitation, identified under NAICS code 541380, is not a request for competitive bids, and the government retains sole discretion in choosing not to compete the contract. However, other interested sources may express their interest and capability to perform the services in writing by a specified deadline, although the government will not compensate respondents for any submissions. The point of contact for inquiries or submissions is Ognian Ivanov, with communications directed to his official email. This acquisition aims to ensure continued access to this unique and critical testing service for veteran patients requiring heart transplant monitoring.

General Info

Sole source contract to Caredx for FDA-approved heart transplant rejection blood testing.

Agency

Department Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Set-Aside

NONE

Documents

36C25722Q0287 - NTX CareDx-Allomap

sources-sought

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PostedJan 30

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

Contacts1 person available

OfficeSan Antonio, TX, 78240, USA

Organization / AgencyDepartment Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

Office AddressSan Antonio, TX, 78240, USA

Contacts

Ognian Ivanov

contact@example.gov

Full Description

The Department of Veterans Affairs, Network Contracting Office 17, located at Plaza LeCea, 5441 Babcock Rd. Ste 302 intends to negotiate a sole source contract with Caredx Inc. (XDX Inc.), 3260 Bayshore Blvd., Brisbane, CA 94005 for AlloMap Transplant Rejection Blood Testing services on behalf Dallas VA Medical Center, Pathology and Lab Medicine Department. The North American Industry Classification System (NAICS) code for this acquisition is 541380. The contract will be awarded as a firm fixed price contract for one base period with four optional renewal periods. The Contractor will provide genetic blood testing, an AlloMap Molecular Expression test only offered by this reference laboratory, to determine if a heart post-transplant patient is rejecting its transplanted organ. This notice of intent is not a request for competitive quotes. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. This type of mapping is only offered by Caredx Inc, and there are no other reference laboratory company s, who offer this specialty molecular mapping test service approved by the FDA. Therefore, responses from other than the above sources may identify their interest and capabilities to perform the requirement by submitting it in writing via email to contact@example.gov no later than February 11, 2022 by 9:00 AM Central Standard Time. The Government will not pay for any information submitted by respondents because of this notice of intent.